Health newsRecent Post

Gene therapy: ‘Now I can see my own face again’

In 2019 the NHS agreed to fund the treatment, Luxturna, the first in a new generation of gene therapies for conditions causing blindness. It costs about £600,000 per patient to treat both eyes, though the NHS has agreed a confidential discount with the makers Novartis.

Source link

Comment here

This site uses Akismet to reduce spam. Learn how your comment data is processed.